Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats

Diabetes

Volumn 54, Issue 1, 2005, Pages 63-68

  Namkoong, Churl ^a   Min, Seon Kim ^b   Pil, Geum Jang ^a   Sung, Min Han ^b   Hye, Sun Park ^a   Koh, Eun Hee ^b   Woo, Je Lee ^b   Jong, Yeon Kim ^c   In, Sun Park ^d   Joong, Yeol Park ^b   Ki, Up Lee ^b  

^a Asan Institute for Life Sciences   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yeungnam University   (South Korea)

^d Inha University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; STREPTOZOCIN;

ANIMAL TISSUE; ARTICLE; CELL ENERGY; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENERGY INTAKE; GENE TRANSFER TECHNIQUES; GENES, MYC; HYPERPHAGIA; HYPOTHALAMUS; INSULIN; LEPTIN; MALE; MULTIENZYME COMPLEXES; ORGAN SIZE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT LOSS;

EID: 19944426367     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.1.63     Document Type: Article

References (27)

1. Booth DA: Some characteristics of feeding during streptoxotocin-induced diabetes in the rat. J Comp Physiol Psychol 80:238-249, 1972
2. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, Gill JS, Burrin JM, Polak JM, Bloom SR: Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37:763-772, 1988
3. Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW: Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes 51:778-783, 2002
4. Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW: Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 49:244-252, 2000
5. Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, Ahren B: Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol 274:R1482-R1491, 1998
6. Sipols AJ, Baskin DG, Schwartz MW: Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44:147-151, 1995
7. Sahu A, Sninsky CA, Kalra PS, Kalra SP: Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198, 1990
8. Sindelar DK, Havel PJ, Seeley RJ, Wilkinson CW, Woods SC, Schwartz MW: Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 48:1275-1280, 1999
9. Hardie DG, Carling D, Carlson M: The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821-855, 1998
10. Rutter GA, Da Silva Xavier G, Leclerc I: Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375:1-16, 2003
11. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF: Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72:1707-1716, 1999
12. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Youn JH, Lee HK, Lee KU: Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10:727-733, 2004
13. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569-574, 2004
14. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ: AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279:12005-12008, 2004
15. Park KS, Kim JH, Kim MS, Kim JM, Kim SK, Choi JY, Chung MH, Han B, Kim SY, Lee HK: Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 50:2837-2841, 2001
16. Davies SP, Carling D, Munday MR, Hardie DG: Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping: effects of high fat diets. Eur J Biochem 203:615-623, 1992
17. Obici S, Feng Z, Arduini A, Conti R, Rossetti L: Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9:756-761, 2003
18. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR: The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 105:1005-1011, 2000
19. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174, 2001
20. Stein SC, Woods A, Jones NA, Davison MD, Carling D: The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345:437-443, 2000
21. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ: A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7:1085-1094, 2001
22. Mercer EH, Hoyle GW, Kapur RP, Brinster RL, Palmiter RD: The dopamine beta-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 7:703-716, 1991
23. Kim MS, Yoon CY, Jang PG, Park HS, Ryu JW, Park YJ, Shin CS, Park JY, Lee KU, Kim YB, Kim SY, Lee HK, Park KS: The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 18:2291-2301, 2004
24. Davies SP, Carling D, Hardie DG: Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186:123-128, 1989
25. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039-E1044, 2000
26. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP: Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:2379-2381, 2000
27. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343, 2002